Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02291718 · ClinicalTrials.gov registry record · Phase 4
Thoracoabdominal Arortic CTA Study
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT02291718 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 150 participants.
The verdict
NCT02291718, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the contrast agents and imaging techniques used for thoracoabdominal aortic imaging in CT. Imaging parameters and contrast volume are changed and adjusted based on the contrast agent, since contrast agents have varying iodine concentrations. If the contrast iodine concentration is higher, it may be possible to adjust the imaging parameters and lower the overall radiation dose to the patient.
Interventions
- DRUG Isovue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02291718
The ClinicalTrials.gov registry entry for NCT02291718 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Isovue is the first listed.
NCT02291718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02291718 about?
NCT02291718 is a clinical study titled "Thoracoabdominal Arortic CTA Study". The purpose of this study is to compare the contrast agents and imaging techniques used for thoracoabdominal aortic imaging in CT. Imaging parameters and contrast volume are changed and adjusted based on the contrast agent, since contrast agents have varying iodine concentrations. If the contrast io...
What is the current status of trial NCT02291718?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2014-01. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02291718?
The interventions under investigation include: Isovue (DRUG).
Who is sponsoring clinical trial NCT02291718?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.